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Abstract
Background Iran is fighting heroically against COVID-19. Due to the importance of scientific publications in better dealing with
this stubborn virus, this study was conducted aiming at reviewing COVID-19 publications by Iranian scientists.
Methods We searched for COVID-19 and all its related keywords in the Web of Science (WOS), Scopus and PubMed databases
to find documents published by Iranian authors until July 10, 2020. Duplicates documents were excluded, and bibliographic
parameters were evaluated. Co-authorship matrix was calculated using Bibexcel, and visualizations were done using VOSviewer.
Results A total of 849 documents from 3450 Iranian researchers (5.5 authors per document) were retrieved fromWOS, PubMed,
and Scopus and Iran ranked 12th and 13th in WOS and Scopus in terms of the number of publications. The average citation per
document was 2.2 with the h-index of 18. Original articles and letters were the most common formats for Iranian publications.
The Journal of Military Medicine has published the highest number of documents. Iranian authors have mostly collaborated with
researchers from the United States, Italy, the UK, and Canada, respectively. The co-occurrence network for keywords represented
five publication clusters in the collection, and the largest clusters were related to epidemiological studies and public health,
followed by clinical studies on COVID-19.
Conclusion Iranian researchers have had a significant scientific contribution in various areas of the disease. However, the
network of studies has not been sufficiently cohesive, and more coherent collaboration between researchers at the national and
international levels should be on the agenda of research policymakers in the country.
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Introduction
The year 2020 did not start well. With the outbreak of the new
coronavirus (COVID-19) in the world, December 29, 2019
became an unforgettable day for the history of global health
and the people of the world. The high prevalence of COVID-
19 with the possibility of its transmission from human to
human [1] and its transcontinental conflict caused the World
Health Organization to declare a pandemic situation in
March 2020 [2]. COVID-19 causes severe respiratory and
intestinal infections in humans [3] and its incubation period
lasts an average of 5 days and its duration is between 4 and
7 days [4]. The main symptoms of COVID-19 include fever,
cough, and shortness of breath, muscle aches, headaches, and
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fatigue [5]. Having common underlying diseases such as high
blood pressure, cardiovascular disease, obesity and diabetes
can affect the impact of the infection and increase the mortal-
ity [6, 7].
According to statistics, as of July 10, 2020 brief,
12,616,578 confirmed cases, 562,039 deaths, and 7,327,360
recovered cases from 215 countries have been reported.
According to the same reports, the United States, Brazil and
India had the highest rates of infection, respectively, and the
United States, Brazil and the United Kingdom had the highest
number of deaths due to Covid-19. Iran, located in the
Southwest Asian, reported its first case of Covid-19 on
February 19, 2020 in Qom, and is now ranked 10th and 9th
in the world with 252,720 confirmed cases and 12,447 deaths
(www.worldometers.info/) due to coronavirus. The advent of
COVID-19 has not only negatively affected health issues, but
has also halted many economic and cultural activities around
the world [8] such that the world is overshadowed by a mi-
croscopic virus.
In order to deal with COVID-19, the publication and dis-
semination of all scientific activities are of particular impor-
tance [9]. This led to a large number of publications on the
subject of COVID-19 in a short period of time, in such a way
that COVID-19 literature published since the onset of the dis-
ease has reached more than 23,000 documents, doubling ev-
ery twenty days [10]. The volume of publications led to sev-
eral studies to evaluate the status of scientific production on
COVID- 19 and its related challenges on a global scale in
bibliometric approach [11–14]. The bibliometric analysis uses
literature metrology characteristics to effectively measure the
contribution of an area of research, to predict detailed trends of
research or hotspots in a particular field, and to make an im-
portant contribution to the prevention and treatment of dis-
eases [13].
Each country has done its own research to answer its ques-
tions about COVID-19 in accordance with its capabilities and
infrastructure. Meanwhile, Iran, as one of the countries suffer-
ing from the high incidence of COVID-19, is no exception.
The scientific output of Iranian researchers is growing.
According to SCImago reports, in 2019, Iran is ranked 15th
in the world with the highest number of publications in the
world [15]. In 2018, Iran was also ranked 31st among the top
50 countries in terms of scientific research published by top
journals in Nature Index, and it has the second highest growth
in this list (26.5%) [16].
Although according to the Iran National Committee for
Ethics in Biomedical Research more than 2600 research pro-
jects and 100 clinical trials are approved for COVID-19 in Iran
[17], to the best of our knowledge, there have been no studies
to evaluate the scientific outcomes of Iranian researchers in
related with COVID-19.
Given the importance of evaluating COVID-19 research
outputs in identifying the status, assisting the future
decision-making, and determining the country’s scientific
road map in the current emergency situation, as well as the
lack of studies in this area, the present study is one of the
pioneering studies conducted so far with a focus on scientific
productions of a particular country with a bibliometric ap-
proach. The study aimed at reviewing the general trend and
scientific publications of Iran on this annoying virus and is
one of the pioneers in terms of scale [18].
Methods
Data source
To identify documents related to COVID-19, a search
strategy containing words related to COVID-19 and affil-
iation to Iran was developed on three databases: Web of
Science, PubMed, and Scopus (search strategy is given in
Appendix 1). Search and retrieval of data was conducted
on July 10, 2020. The criteria for entering the documents
into this study included all types of documents listed in
the databases as mentioned above, in which at least one
author with organizational affiliation to Iranian institu-
tions was present. After extracting the documents and re-
moving duplicate items in the Endnote software, a
combined set of three databases were created. This set
was used to analyze the co-authorship network and the
co-occurrence network for keywords. For other
scientometrics indicators that could not be reported in
the form of a combined set of three databases, data
obtained by the Scopus database, which is perceived as
a more comprehensive and reliable bibliographic source
in terms of the number of results than the other two
databases, was reported.
Bibliometric parameters
In this study, the bibliometric indicators at the level of docu-
ments (number of documents, document type, number of
citations, highly cited documents, average citation and h-
index) and author (number of authors, average author per doc-
ument, the most prolific and most highly cited author) were
examined. Also, the knowledge structure of this set was ana-
lyzed at the level of social structure (co-authorship network
and international cooperation network) and at the level of
conceptual structure (co-occurrence network for keywords)
and their network was visualized.
Network visualization
The VOSviewer v1.6.15 [19] software was used to analyze the
co-occurrence network for keywords and co-authorship net-
work. VOSviewer is a free software that can draw bibliometric
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networks at different levels of countries, organizations,
journals, researchers, or individual publications using biblio-
graphic data. Also, the text mining feature of this software has
made it possible to construct and visualize the co-occurrence
network for keywords.
In order to construct the co-occurrence network for key-
words, the keywords of different documents were first unified
in terms of various forms of writing, and then the keywords
that were present in at least 5 documents were extracted, and
their co-occurrence network was constructed. In order to bet-
ter clarify the network, general words seen in most studies,
such as demographic characteristics (male, female, child,
adult, etc.) and document types (case report, systematic re-
view, cross-sectional study, etc.) were removed from the key-
word network.
For the co-authorship network, the co-authorship matrix of
authors who participated in writing at least 3 documents (234
authors) was calculated by the software [10] Bibexcel V2016-
02-20 and the VOSviewer software was used to visualize the
network.
Network density was also calculated using the UCINET
v6.695 software to identify the state of connectedness of the
network nodes. Network density is the number of actual direct
links between network nodes (authors) relative to the total
number of potential connections in the network, which can
be between 0 and 1 [20]. Density one means that all authors
are directly related to each other, and zero density implies the
isolation of authors and the absence of any connection be-
tween them.
Results
As of July 10, 2020, 382 documents have been indexed
on the Web of Science, 638 on the Scopus, and 631 on
the PubMed databases. Out of 1651 documents retrieved
in the three databases, 802 duplicate documents were re-
moved from the set, and finally 849 documents were iden-
tified with the participation of 3450 independent authors
and were selected for the analysis of co-authorship and
co-occurrence network for keywords. Of the 638 docu-
ments by Iranian authors listed on the Scopus, the original
articles and letters each account for 38.9% and 33.2% of
the publications, respectively, and the rest of the docu-
ments were published in the form of editorials, research
notes, and short reviews. Table 1 shows the characteristics
of documents by Iranian authors published on COVID-19.
In total, Iranian studies in the field of COVID-19 re-
ceived 1427 citations in the Scopus database. The average
citation per document in this set was 2.2 and the h-index
was 18. Table 2 shows a list of ten most frequently cited
documents, along with the number of citations and their
document type.
We found that Rezaei N with 24, Haseli S with 15 and
Tabarsi P with 10 documents were the most active Iranian
authors in the field of COVID-19 studies. The list of 10
most prolific COVID-19 research authors in terms of the
number of documents and citations is presented in
Table 3.
Among the medical journals hosting research related to
COVID 19, the Journal of Military Medicine published the
most significant number of documents. Table 4 shows a list of
ten journals with the highest number of documents related to
Covid-19 along with the subject area, their quartile, and the
number of citations received from COVID-19 related
documents.
In terms of the number of publications, Iran ranked
12th in the Web of Science database. The largest share
in the publication of documents was by researchers from
the United States and China. According to the Scopus,
Iran ranked 13th and US researchers with 100, Italy with
42, the UK with 33 and Canada with 32 documents had
the most collaboration with Iranian researchers (see
Fig. 1).
The authorship distribution pattern indicated that
68.6% (582) of documents were written in small groups
of 1 to 5 authors, 23.3% (198) in groups with 6 to 10
authors and 8.1% (69) in groups with more than 10 au-
thors. The average number of authors per document was
calculated 5.5. The co-authorship network of published
documents is shown in Fig. 2. In this network, 234
Table 1 Iranian COVID-19 documents characteristics
Description Finding
No. of documents
Documents in WOS 382
Documents in PubMed 631
Documents in Scopus 638
Total Documents (After duplicates removed) 849
Authors
Total Authors 4706
Avg. Authors per Document 5.5
Document Type (Scopus)
Article 248 (38.8%)
Letter 212 (33.2%)
Review 104 (16.3%)
Editorial 38 (5.9%)
Note 34 (5.3%)
Short Communication 2 (0.3%)
Citation (Scopus)
Total Citations 1427
Avg. Citations per Documents 2.2
H-index 18
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authors were connected to each other by 1208 links and
form a network with a density of 0.022. The network
consisted of a more extensive network with 156 authors
(66.66%) and 23 small components (sub-network).
The co-occurrence network for keywords, shown in Fig. 3,
consisted of five intertwined clusters of keywords, the topics
of which were:
Cluster 1 (Red):With 21 keywords such as “pandemic”,
“epidemiology”, “disease outbreak”, and “public health”,
the cluster showed epidemiological and public health
studies on COVID-19.
Cluster 2 (Green): With 19 keywords such as
“remdesivir”, “chloroquine”, “immunotherapy”, “disease
transmission” showed clinical studies, signs and symp-
toms of the disease, and pharmacological and non-
pharmacological interventions for COVID-19.
Cluster 3 (Blue): With 13 keywords such as
“Pneumonia”, “mortality”, “Virus detection”, “PCR”,
“fever”, showed signs and symptoms of the disease, clin-
ical consequences and diagnostic methods for COVID-
19.
Cluster 4 (Yellow): With 8 keywords such as “COVID-
19”, “Coronavirus”, “SARS-COV-2”, etc., mostly repre-
sented the documents introducing the virus that caused
COVID-19 disease.
Cluster 5 (Purple): The smallest network cluster, with 3
keywords, including “cancer”, “hypertension” & “diabe-
tes mellitus”, showed evidence of the role of underlying
diseases associated with COVID-19.
Discussion
By the time of this study, 849 documents contributed by 4706
Iranian authors were retrieved from three databases of Scopus,
Table 4 The 10 most published journals
Rank Sources Subject Area Q CiteScore NP Citation Avg.
CPP
1 Journal of Military Medicine Public Health, Environmental and Occupational
Health
4 0.5 22 26 1.2
2 Academic Radiology Radiology, Nuclear Medicine and Imaging 2 3.9 17 19 1.1
3 Infection Control and Hospital Epidemiology Infectious Diseases 2 4.5 17 21 1.2
4 Iranian Journal of Public Health Public Health, Environmental and Occupational
Health
4 0.9 16 6 0.4
5 Archives of Clinical Infectious Diseases Critical Care and Intensive Care Medicine 3 1.0 15 15 1.0
6 Archives of Medical Research General Medicine 1 3.3 13 18 1.4
7 Archives of Iranian Medicine General Medicine 1 2.2 12 32 2.7
8 Medical Journal of The Islamic Republic of
Iran
General Medicine 2 0.9 12 7 0.6
9 Medical Hypotheses General Medicine 1 2.2 11 8 0.7
10 Dermatologic Therapy Dermatology 2 1.8 10 28 2.8
Q: Subject area quartile in Scopus. NP: Number of publications. Avg. CPP: Average Citations per Publication
Table 3 Top 10 Prolific authors in Iranian COVID-19 studies in terms of number of records and total citation (Scopus)
Rank Authors No. of records % of 849 Authors T. Citation
1 Rezaei N 24 2.8 Aghamohammadi N 112
2 Haseli S 15 1.8 Baghbanzadeh M 112
3 Tabarsi P 10 1.2 Rezaei N 69
4 Dadkhahfar S 9 1.1 Dadar M 69
5 Taheri MS 9 1.1 Safari S 60
6 Goldust M 9 1.1 Aminian A 58
7 Lotti T 9 1.1 Karimi N 57
8 Saffaei A 9 1.1 Ghorbani M 55
9 Sadoughifar R 9 1.1 Falahati M 47
10 Badrfam R 8 0.9 Sharifi M 47
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PubMed and Web of Science. Iran ranked 12th and 13th,
respectively, in terms of the number of publications in the
Web of Science and Scopus. The average number of authors
per document was about 5.5, and original articles and letters,
each having a share of about 39% and 33% respectively, was
the most common format for Iranian publications. The aver-
age citation for each retrieved document was 2.2 and their h-
index was 18.
The results of the study showed that after “original
article”, the “letter” was one of the main document types
published in the field of COVID-19 researches [8, 14].
The high prevalence of COVID-19 and global struggles
to detect unknowns about the virus appear to have
prompted researchers to select the letter as the shortest
and fastest way to disseminate scientific information.
However, since more time is needed to complete studies
in the field of COVID-19, original articles in the peer
review process are usually published later. Reassessment
after a sufficient period of time can better reflect the ac-
tivities of researchers in this field.
In our study, the average citation per document on Scopus
was 2.2, and the h-index was 18, which was slightly higher
than the global average in the field of COVID-19 [21].
However, according to the published results, in the section
of highly cited documents, the citation status of documents
published by Iranian researchers seems to be acceptable com-
pared to other studies [18, 22]. It should be noted that the
selection of high-quality journals can lead to high visibility
and impact [23] and thus, the produced knowledge could
optimally cope with the COVID-19 disease.
Due to the severe shortage of research budgets, Iranian
researchers are limited in their choice of open access journals
[24]. On the other hand, some medical journals, in addition to
unilateral US sanctions, avoid accepting manuscripts submit-
ted by Iranian researchers, directly or indirectly [25].
Therefore, researchers have published most of their docu-
ments in Iranian journals. Further investigation revealed that
most of the citations are received by review articles. This is
while the original articles of COVID-19 are more popular
worldwide than other types of documents in terms of citation
Fig. 1 Iran international collaboration map of documents indexed in Scopus
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[22]. Therefore, despite the value of other forms of document
types, writing original articles can contribute more to the ad-
vancement of science.
A review of the most prolific journals showed that most of
them are from domestic publications and are in the top
journals in their field. Only a small number of top documents
contributed by Iranian researchers were published in top
journals in the field of medical sciences, and only in a few
of them the corresponding author was Iranian. It is recom-
mended that researchers identify and select journals with more
visibility indicators. However, Iranian researchers have
attempted to exchange and access each other’s opinions in
the field of COVID-19 by establishing scientific collabora-
tions with researchers from prominent countries, such as the
United States and Italy [14]. Strengthening international col-
laborations can help researchers achieve effective results.
Therefore, identifying the factors that strengthen or weaken
scientific collaboration should be on the agenda of research
policymakers in the country.
Our study showed that the COVID-19 network of Iranian
researchers with a density of 0.022 suffers from low coher-
ence. This density means that the authors of COVID-19-
related studies used only 2.2% of the potential links between
the authors, so the authors on this network have a low level of
connection with each other, and their maximum capacity is
not used in the network. Research teams independently con-
ducted COVID-19 studies in Iran in 24 small sub-networks.
This may be due to the heterogeneous incidence of the disease
in different parts of the country. Also, most of the researchwas
done in small scientific groups of less than 5 authors.
However, compared to COVID-19 studies in the world [21],
Iranian studies have larger teams. Given the current state of
emergency and the impact of group collaboration on the qual-
ity of publications [26], researchers should be encouraged to
Fig. 2 Co-authorship network of Iranian researchers on COVID-19
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increase collaboration by increasing their connection with net-
work members. The formation of more cohesive research
teams and broader research networks can lead to the promo-
tion of publications, which is possible through research policy
making by higher authorities.
Evaluation of the co-occurrence network for keyword
showed that researches by Iranian authors have covered a
wide range of COVID-19-related areas, including: epidemiol-
ogy, pharmaceutical and non-pharmaceutical interventions,
clinical aspects including disease symptoms, diagnostic
methods, virology, and underlying diseases. Despite the diver-
sity of the virus’s faces, studying in other areas should not be
neglected to understand it further.
Strengths and limitations
In this study, an investigation of research documents pub-
lished in the subject area of COVID-19 was carried out at
the national level, which has rarely been done in such a scale.
In addition, we searched for data from three reliable Web of
Science, Scopus, and PubMed databases that show the scope
of the work. Although this approach has covered a large por-
tion of COVID-19 publications by Iranian researchers, but
some publications by Iranian authors indexed in National
(Persian) databases, Preprint databases (such as medRxiv
and bioRxiv), and those articles that have yet to be published
have not been retrieved in the present research, which is one of
the limitations of this study.
Conclusion
Iranian researchers have made significant contributions to the
publication of documents on COVID-19, and a variety of
areas of the disease have been covered by them. However,
the co-authorship network of studies is not sufficiently
coherent. Therefore, a more consistent collaboration of
research networks in the country and strengthening
international collaboration should be on the agenda of
research policymakers in the country.
Fig. 3 Co-occurrence of keywords in documents related to COVID-19 published by Iranian researchers
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Appendix 1: Search Strategy
Database Search strategy Execution
date
No. of
records
PubMed (“Coronavirus Infections”[Mesh] OR”covid-19”[Title/Abstract] OR
“COVID19”[Title/Abstract] OR ((“CoV”[Title/Abstract] OR
“coronavirus”[Title/Abstract] OR “nCoV”[Title/Abstract] OR “novel
coronavirus”[Title/Abstract]) AND (“19”[Title/Abstract] OR
“2019”[Title/Abstract])) OR “Wuhan coronavirus”[Title/Abstract] OR
“SARS-CoV-2”[Title/Abstract] OR “SARS2”[Title/Abstract]) AND
“iran”[Affiliation](“Coronavirus Infections”[Mesh]
OR”covid-19”[Title/Abstract] OR “COVID19”[Title/Abstract] OR
((“CoV”[Title/Abstract] OR “coronavirus”[Title/Abstract] OR
“nCoV”[Title/Abstract] OR “novel coronavirus”[Title/Abstract]) AND
(“19”[Title/Abstract] OR “2019”[Title/Abstract])) OR “Wuhan
coronavirus”[Title/Abstract] OR “SARS-CoV-2”[Title/Abstract] OR
“SARS2”[Title/Abstract]) AND “iran”[Affiliation] AND (“2019/10″[Date -
Publication]: “3000″[Date - Publication])
10
July 2020
631
Web of Science
(Indexes: SCI-EXPANDED, SSCI,
A&HCI, CPCI-S, CPCI-SSH, ESCI.)
(ts = (“covid-19” OR “COVID19” OR ((“CoV” OR “coronavirus” OR “nCoV”
OR “novel coronavirus”) AND (“19” OR “2019”)) OR “Wuhan coronavirus”
OR “SARS-CoV-2” OR “SARS2”)) AND cu = iran
10
July 2020
382
Scopus TITLE-ABS-KEY ((“covid-19”OR “COVID19”OR ((“CoV”OR “coronavirus”
OR “nCoV” OR “novel coronavirus”) AND (“19” OR “2019”)) OR “Wuhan
coronavirus” OR “SARS-CoV-2” OR “SARS2”)) AND AFFILCOUNTRY
(iran) AND PUBYEAR >2018
10
July 2020
638
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